Presentation 2_Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation.pptx

Background and purpose<p>Promoting adaptive immunity with ICIs has drastically improved melanoma prognosis, but not for all patients. Some cases relapse in the first few months, while others keep durable benefit, even after immunotherapy discontinuation. To identify cellular/molecular signatur...

Full description

Saved in:

Bibliographic Details
Main Author:	Eleni Palli (4558156) (author)
Other Authors:	Matthieu Lavigne (17308408) (author), Panagiotis Verginis (20950934) (author), Themis Alissafi (15126709) (author), Amalia Anastasopoulou (14798728) (author), Georgios Lyrarakis (20950937) (author), John M. Kirkwood (9665412) (author), Helen Gogas (91945) (author), Dimitrios C. Ziogas (8564346) (author)
Published:	2025
Subjects:	Genetic Immunology immune checkpoint inhibitors immunotherapy resistance CD4+T-cells differentially expressed genes bulk RNA-seq
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Presentation 2_Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation.pptx

Similar Items